Patient’s Preferences in the Treatment of Vitiligo – A Discrete Choice Experiment

• Conditions: L80; Vitiligo

• Registration Number: DRKS00032201
• Lead Sponsor: Hochschule Neubrandenburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Diagnosis: Vitiligo
Resident in Germany
Able to read and understand German

Exclusion Criteria

Age <18 years
Diagnosis: No Vitiligo
Not resident in Germany
Not able to read and understand German

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To elicit the trade-offs that vitiligo patients make when treatment is clinically indicated and thus identify the weighting of characteristics of a treatment (preferences).

Secondary Outcome Measures

Name	Time	Method
Secondary objectives are benefit-risk assessment to estimate patient maximum level of acceptable risk of treatment-related sides effects, the overall comparison to assess the relative importance of attributes and adherence to identify key attributes that affect patients’ willingness to adhere to topical treatment options. Exploratory objectives are the analysis of heterogeneity to assess how preferences differ based on respondents' characteristics and the identification of personas or subgroups to explore and explain heterogeneity based on the correlation between preferences and sociodemographic information, experience-based treatment history and attitudes of the respondents.